China's National Cancer Prevention and Treatment Week
Release Date 2025-04-15

April 15–21 marks China's National Cancer Prevention and Treatment Week, a time to raise awareness about cancer, promote early detection, and highlight the importance of integrated diagnostic solutions.

Cancer remains a leading cause of death globally. According to the World Health Organization, nearly 1 in 6 deaths worldwide is due to cancer, over 35 million new cancer cases are predicted in 2050. Early and precise diagnosis is critical to improving survival rates and treatment outcomes.

Cancer mortality is reduced when cases are detected and treated early. There are two components of early detection: early diagnosis and screening. Many cancers have a high chance of cure if diagnosed early and treated appropriately.

微信图片_20250415094258.jpg

At #KHB & #Tianlong, we are committed to advancing cancer diagnostics with our Overall Detection Solution for Oncology—a comprehensive approach tailored for cancer detection, early diagnosis, and personalized treatment planning. Our solution integrates:

  • Biomarker Analysis

  • Genetic & Molecular Testing

  • Personalized Medicine

This comprehensive platform covers high-risk cancer areas such as liver cancer, gastric cancer, lung cancer, and multiple myeloma, providing clinicians with a broad yet in-depth diagnostic view.

What’s included?
KHB’s #Biochemistry, #Chemiluminescence and #ELISA Test Menu offers a wide panel of tumor markers, including:

  • AFP, CEA, CA125, CA15-3, CA19-9

  • t-PSA, f-PSA, HE4, NSE, CYFRA21-1

  • proGRP, G-17, SCCA, PIVKA II*

  • Fer, PGI, PGII

Tianlong’s #Molecular Diagnostics Portfolio includes:

  • Oncogenic virus detection: HPV, HBV, HCV, EB

  • Genetic testing for personalized therapy: K-Ras, B-Raf, Breast Cancer, Colorectal Cancer, Acute Lymphocytic Leukemia

By combining biochemical, immunological, and molecular insights, our solution empowers healthcare professionals with the tools they need for early detection, accurate diagnosis, and personalized cancer treatment—ultimately improving patient outcomes.

Let’s work together to build a future where cancer is no longer a silent killer.

Share
Recommendation